Massive trial tests azithromycin to prevent stillbirths in High-Risk region
NCT ID NCT03909737
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 32 times
Summary
This large study in Mali, West Africa, tests whether giving the antibiotic azithromycin to pregnant women and their babies can prevent stillbirths and infant deaths. Over 99,000 participants are involved. The goal is to find a simple, low-cost way to save lives in an area with very high infant mortality.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STILLBIRTHS AND INFANT MORTALITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre pour le Developpement des Vaccins - Mali
Bamako, Mali
Conditions
Explore the condition pages connected to this study.